Literature DB >> 17448641

Usefulness of intracranial EEG in the decision process for epilepsy surgery.

Margarita Pondal-Sordo1, David Diosy, José F Téllez-Zenteno, Ramesh Sahjpaul, Samuel Wiebe.   

Abstract

BACKGROUND AND
PURPOSE: In patients with discordant results, non-localizing EEG, or bitemporal seizure onset, intracranial monitoring is done to confirm the seizure onset. Our aim was to assess the yield of intracranial recordings in patients with different clinical scenarios.
METHODS: The records of all patients who underwent prolonged intracranial EEG monitoring (IEM) at the London Health Sciences Centre, University of Western Ontario, Canada, between 1993 and 1999, identified using our EEG patient database in continuous use since December 1972, were reviewed. Patients were analyzed in the following groups according to perceived increasing degrees of uncertainty of epileptic zone localization-group 1: lesion on MRI congruent with focal ictal and interictal scalp EEG, but findings are subtle and of low level of certainty (n=13), group 2: focal MRI, focal ictal and multifocal interictal scalp EEG (n=11), group 3: focal MRI, non-localizing or incongruent scalp EEG (n=73), group 4: normal of multifocal MRI, focal ictal scalp EEG (n=11), group 5: multifocal MRI, non-localizing scalp EEG (n=18), and group 6: normal MRI, multifocal scalp EEG (n=36).
RESULTS: One hundred and seventy one patients underwent IEM at the London Health Sciences Centre between 1993 and 1999. All patients had localization-related epilepsy, plus or minus secondary generalization. IEM was helpful overall in 86% of patients, in 69% of group 1, 36% of group 2, 90% of group 3, 81% of group 4, 100 of group 5 and 92% of group 6.
CONCLUSIONS: Our study shows that the yield of the IEM was higher in the groups of patients with lack of congruence between the MRI and the scalp EEG. The yield was lower in patients with congruent but subtle or uncertain scalp EEG and MRI findings.

Entities:  

Mesh:

Year:  2007        PMID: 17448641     DOI: 10.1016/j.eplepsyres.2007.03.011

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  7 in total

1.  A novel method for the identification of synchronization effects in multichannel ECoG with an application to epilepsy.

Authors:  A Graef; M Hartmann; C Flamm; C Baumgartner; M Deistler; T Kluge
Journal:  Biol Cybern       Date:  2013-02-22       Impact factor: 2.086

Review 2.  Preoperative evaluation and surgical decision-making in pediatric epilepsy surgery.

Authors:  Katrina Ducis; Jian Guan; Michael Karsy; Robert J Bollo
Journal:  Transl Pediatr       Date:  2016-07

Review 3.  Surgical strategies for pediatric epilepsy.

Authors:  Jian Guan; Michael Karsy; Katrina Ducis; Robert J Bollo
Journal:  Transl Pediatr       Date:  2016-04

4.  Diagnostic outcome of surgical revision of intracranial electrode placements for seizure localization.

Authors:  Ricky W Lee; Gregory A Worrell; W Richard Marsh; Gregory D Cascino; Nicholas M Wetjen; Fredric B Meyer; Elaine C Wirrell; Elson L So
Journal:  J Clin Neurophysiol       Date:  2014-06       Impact factor: 2.177

5.  Intraoperative optical mapping of epileptogenic cortices during non-ictal periods in pediatric patients.

Authors:  Yinchen Song; Jorge J Riera; Sanjiv Bhatia; John Ragheb; Claudia Garcia; Alexander G Weil; Prasanna Jayakar; Wei-Chiang Lin
Journal:  Neuroimage Clin       Date:  2016-02-26       Impact factor: 4.881

6.  Congruence and Discrepancy of Interictal and Ictal EEG With MRI Lesions in Pediatric Epilepsies.

Authors:  Jan Rémi; Sophie Shen; Moritz Tacke; Philipp Probst; Lucia Gerstl; Aurelia Peraud; Mathias Kunz; Christian Vollmar; Soheyl Noachtar; Ingo Borggraefe
Journal:  Clin EEG Neurosci       Date:  2020-05-18       Impact factor: 1.843

7.  Influence analysis for high-dimensional time series with an application to epileptic seizure onset zone detection.

Authors:  Christoph Flamm; Andreas Graef; Susanne Pirker; Christoph Baumgartner; Manfred Deistler
Journal:  J Neurosci Methods       Date:  2013-01-24       Impact factor: 2.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.